These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 2184899

  • 61. Further investigation of the dexamethasone suppression test in affective illnesses: relationship to clinical diagnosis and therapeutic response.
    Mendlewicz J, Hubain PP, Koumakis C.
    Neuropsychobiology; 1984; 12(1):23-6. PubMed ID: 6514175
    [Abstract] [Full Text] [Related]

  • 62. Evolution of red blood cell membrane transport and plasma level of L-tyrosine and L-tryptophan in depressed treated patients according to clinical improvement.
    Bovier P, Widmer J, Gaillard JM, Tissot R.
    Neuropsychobiology; 1988; 19(3):125-34. PubMed ID: 3143923
    [Abstract] [Full Text] [Related]

  • 63. A comparison of the cortisol suppression index and the dexamethasone suppression test.
    Laux G, Schlesser MA, Rush AJ, Orsulak P, Weissenburger J.
    J Clin Psychiatry; 1984 Oct; 45(10):431-2. PubMed ID: 6480568
    [Abstract] [Full Text] [Related]

  • 64. No early effects of electroconvulsive therapy on tryptophan metabolism and disposition in endogenous depression.
    Mokhtar AS, Morgan CJ, Bradley DM, Badawy AA.
    Biol Psychiatry; 1997 Aug 01; 42(3):201-5. PubMed ID: 9232212
    [Abstract] [Full Text] [Related]

  • 65. Depressive psychomotor disturbance, cortisol, and dexamethasone.
    Mitchell P, Hadzi-Pavlovic D, Parker G, Hickie I, Wilhelm K, Brodaty H, Boyce P.
    Biol Psychiatry; 1996 Nov 15; 40(10):941-50. PubMed ID: 8915553
    [Abstract] [Full Text] [Related]

  • 66. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
    Carson SW, Halbreich U, Yeh CM, Asnis G, Goldstein S.
    Biol Psychiatry; 1988 Sep 15; 24(5):569-77. PubMed ID: 3167145
    [Abstract] [Full Text] [Related]

  • 67. Hormonal differences between psychotic and non-psychotic melancholic depression.
    Contreras F, Menchon JM, Urretavizcaya M, Navarro MA, Vallejo J, Parker G.
    J Affect Disord; 2007 Jun 15; 100(1-3):65-73. PubMed ID: 17098292
    [Abstract] [Full Text] [Related]

  • 68. Free tryptophan response to intravenous insulin in depressed patients.
    Menna-Perper M, Swartzburg M, Mueller PS, Rochford J, Manowitz P.
    Biol Psychiatry; 1983 Jul 15; 18(7):771-80. PubMed ID: 6351935
    [Abstract] [Full Text] [Related]

  • 69. Interepisode consistency of dexamethasone suppression test results in affective disorders.
    Brizer DA, Brown RP, Kocsis JH, Stokes PE.
    Am J Psychiatry; 1986 Apr 15; 143(4):539-41. PubMed ID: 3953899
    [Abstract] [Full Text] [Related]

  • 70. Plasma tryptophan and five other amino acids in depressed and normal subjects.
    DeMyer MK, Shea PA, Hendrie HC, Yoshimura NN.
    Arch Gen Psychiatry; 1981 Jun 15; 38(6):642-6. PubMed ID: 7247626
    [Abstract] [Full Text] [Related]

  • 71. Dexamethasone suppression test in a pluridiagnostic approach: its relationship to psychopathological and clinical variables.
    Kasper S, Beckmann H.
    Acta Psychiatr Scand; 1983 Jul 15; 68(1):31-7. PubMed ID: 6613617
    [Abstract] [Full Text] [Related]

  • 72. Dexamethasone suppression test in primary depression: significance of family history and psychosis.
    Rudorfer MV, Hwu HG, Clayton PJ.
    Biol Psychiatry; 1982 Jan 15; 17(1):41-8. PubMed ID: 7059638
    [Abstract] [Full Text] [Related]

  • 73. Specificity of the salivary cortisol dexamethasone suppression test across psychiatric diagnoses.
    Copolov DL, Rubin RT, Stuart GW, Poland RE, Mander AJ, Sashidharan SP, Whitehouse AM, Blackburn IM, Freeman CP, Blackwood DH.
    Biol Psychiatry; 1989 Apr 01; 25(7):879-93. PubMed ID: 2720003
    [Abstract] [Full Text] [Related]

  • 74. The 2-mg dexamethasone suppression test in differentiating major depression with psychosis from schizophrenia.
    Clower CG.
    J Clin Psychopharmacol; 1986 Dec 01; 6(6):363-5. PubMed ID: 3805330
    [Abstract] [Full Text] [Related]

  • 75. Seasonal variation in neuroendocrine and mood responses to i.v. L-tryptophan in depressed patients and healthy subjects.
    Cappiello A, Malison RT, McDougle CJ, Vegso SJ, Charney DS, Heninger GR, Price LH.
    Neuropsychopharmacology; 1996 Nov 01; 15(5):475-83. PubMed ID: 8914120
    [Abstract] [Full Text] [Related]

  • 76. Relationship between plasma ratio of tryptophan to competing amino acids and the response to L-tryptophan treatment in endogenously depressed patients.
    Møller SE, Kirk L, Honoré P.
    J Affect Disord; 1980 Mar 01; 2(1):47-59. PubMed ID: 6448880
    [Abstract] [Full Text] [Related]

  • 77. Decreased serum dipeptidyl peptidase IV activity in major depression.
    Maes M, De Meester I, Vanhoof G, Scharpé S, Bosmans E, Vandervorst C, Verkerk R, Minner B, Suy E, Raus J.
    Biol Psychiatry; 1991 Sep 15; 30(6):577-86. PubMed ID: 1681947
    [Abstract] [Full Text] [Related]

  • 78. Differential response of plasma glucose, amino acids and nonesterified fatty acids to insulin in depressed patients.
    Menna-Perper M, Rochford J, Mueller PS, Swartzburg M, Jekelis AW, Manowitz P.
    Psychoneuroendocrinology; 1984 Sep 15; 9(2):161-71. PubMed ID: 6382374
    [Abstract] [Full Text] [Related]

  • 79. Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response.
    Maes M, Verkerk R, Vandoolaeghe E, Van Hunsel F, Neels H, Wauters A, Demedts P, Scharpé S.
    Eur Arch Psychiatry Clin Neurosci; 1997 Sep 15; 247(3):154-61. PubMed ID: 9224908
    [Abstract] [Full Text] [Related]

  • 80. Plasma tryptophan and anorexia in human cancer.
    Rossi Fanelli F, Cangiano C, Ceci F, Cellerino R, Franchi F, Menichetti ET, Muscaritoli M, Cascino A.
    Eur J Cancer Clin Oncol; 1986 Jan 15; 22(1):89-95. PubMed ID: 3456893
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.